Epidermolysis Bullosa

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Improve Adherence to Weak or Strong Opioid Analgesics at the Time of Care in Children With Hereditary Epidermolysis Bullosa

Thera-Clean® Microbubbles System in Patients With Skin Diseases

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling

Reproductive Options in Inherited Skin Diseases

Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution

Pregabalin Treatment for RDEB Pain and Itch

MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

Study of Cellutome System for Treatment of Individual Lesions in EB Pts

Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Computational Drug Repurposing for All EBS Cases

Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients

Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa